Nicole Legros

1.5k total citations
40 papers, 1.2k citations indexed

About

Nicole Legros is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Nicole Legros has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 17 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Nicole Legros's work include Estrogen and related hormone effects (22 papers), Metabolism, Diabetes, and Cancer (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Nicole Legros is often cited by papers focused on Estrogen and related hormone effects (22 papers), Metabolism, Diabetes, and Cancer (5 papers) and Bioactive Compounds and Antitumor Agents (4 papers). Nicole Legros collaborates with scholars based in Belgium, United Kingdom and United States. Nicole Legros's co-authors include Jean-Claude Heuson, Guy Leclercq, Willy F. Piessens, Robert Paridaens, Richard Sylvester, Linda Hardy, Eros Ferrazzí, Michael Jarman, Raymond McCague and A. B. Foster and has published in prestigious journals such as Nature, Cancer and Journal of Medicinal Chemistry.

In The Last Decade

Nicole Legros

40 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Legros Belgium 20 545 544 353 261 183 40 1.2k
Mels Sluyser Netherlands 22 604 1.1× 472 0.9× 288 0.8× 135 0.5× 141 0.8× 75 1.2k
Eric C. Dietze United States 20 663 1.2× 200 0.4× 456 1.3× 288 1.1× 57 0.3× 44 1.3k
Rajeshwari R. Mehta United States 19 635 1.2× 204 0.4× 308 0.9× 129 0.5× 44 0.2× 34 1.3k
Hideya Endo Japan 22 825 1.5× 231 0.4× 97 0.3× 178 0.7× 156 0.9× 65 1.1k
Peter Ove United States 24 894 1.6× 176 0.3× 190 0.5× 238 0.9× 93 0.5× 54 1.7k
Karen J. Auborn United States 29 1.3k 2.3× 652 1.2× 406 1.2× 209 0.8× 48 0.3× 51 2.3k
Stephanie J. Webb United States 9 533 1.0× 139 0.3× 146 0.4× 239 0.9× 168 0.9× 9 980
J.C. Faye France 12 263 0.5× 317 0.6× 113 0.3× 63 0.2× 170 0.9× 25 667
Joan Cao United States 13 512 0.9× 312 0.6× 260 0.7× 196 0.8× 57 0.3× 21 1.3k
Debajit K. Biswas United States 19 1.1k 2.0× 288 0.5× 665 1.9× 667 2.6× 88 0.5× 43 1.8k

Countries citing papers authored by Nicole Legros

Since Specialization
Citations

This map shows the geographic impact of Nicole Legros's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Legros with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Legros more than expected).

Fields of papers citing papers by Nicole Legros

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Legros. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Legros. The network helps show where Nicole Legros may publish in the future.

Co-authorship network of co-authors of Nicole Legros

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Legros. A scholar is included among the top collaborators of Nicole Legros based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Legros. Nicole Legros is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nonhoff, C., et al.. (2008). Comparison of three chromogenic media and enrichment broth media for the detection of methicillin-resistant Staphylococcus aureus from mucocutaneous screening specimens. European Journal of Clinical Microbiology & Infectious Diseases. 28(4). 363–369. 48 indexed citations
2.
Gupta, R., et al.. (1999). Synthesis and biological activity of some D-ring modified estrone derivatives. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 38(5). 563–571. 5 indexed citations
3.
Larsimont, Denis, et al.. (1998). Estrogenic and anti-estrogenic regulation of estrogen receptor in MCF-7 breast-cancer cells: Comparison of immunocytochemical data with biochemical measurements. International Journal of Cancer. 78(6). 760–765. 32 indexed citations
4.
Legros, Nicole, et al.. (1998). Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast-cancer cell lines. Cancer Chemotherapy and Pharmacology. 41(4). 339–342. 9 indexed citations
5.
Legros, Nicole, Jin Li, & Guy Leclercq. (1997). Tamoxifen-induced estrogen receptor up-regulation in mammary tumor cells is not related to growth inhibition. Cancer Chemotherapy and Pharmacology. 39(4). 380–382. 7 indexed citations
6.
7.
Laı̈os, Ioanna, et al.. (1996). Estrogenic and antiestrogenic regulation of the half-life of covalently labeled estrogen receptor in MCF-7 breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 57(3-4). 203–213. 43 indexed citations
8.
Hardy, Linda, et al.. (1994). Estradiol-induced Down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. The Journal of Steroid Biochemistry and Molecular Biology. 48(4). 325–336. 110 indexed citations
9.
10.
Leclercq, Guy, Nicole Legros, & Martine Piccart. (1992). Accumulation of a non-binding form of estrogen receptor in MCF-7 cells under hydroxytamoxifen treatment. The Journal of Steroid Biochemistry and Molecular Biology. 41(3-8). 545–552. 24 indexed citations
11.
Legros, Nicole, Guy Leclercq, & Raymond McCague. (1991). Effect of estrogenic and antiestrogenic triphenylethylene derivatives on progesterone and estrogen receptors levels of MCF-7 cells. Biochemical Pharmacology. 42(9). 1837–1841. 4 indexed citations
12.
Roy, Frans van, Marcus Mareel, Kris Vleminckx, et al.. (1990). Hormone sensitivity in vitro and in vivo of v‐ras‐transfected mcf‐7 cell derivatives. International Journal of Cancer. 46(3). 522–532. 16 indexed citations
13.
Andry, Guy, Stefan Suciu, Richard Sylvester, et al.. (1989). Relation between estrogen receptor concentration and clinical and histological factors: Their relative prognostic importance after radical mastectomy for primary breast cancer. European Journal of Cancer and Clinical Oncology. 25(2). 319–329. 28 indexed citations
14.
McCague, Raymond, Guy Leclercq, Nicole Legros, et al.. (1989). Derivatives of tamoxifen. Dependence of antiestrogenicity on the 4-substituent. Journal of Medicinal Chemistry. 32(12). 2527–2533. 90 indexed citations
15.
Madeddu, Luisa, et al.. (1988). Estrogen receptor status and estradiol sensitivity of MCF-7 cells in exponential growth phase. European Journal of Cancer and Clinical Oncology. 24(3). 385–390. 17 indexed citations
16.
Lespagnard, Laurence, et al.. (1987). In vitro Studies of Canine Mammary Tumors: Influence of 17-Beta-Estradiol and Progesterone on Cell Kinetics Parameters. Oncology. 44(5). 292–301. 7 indexed citations
17.
Leclercq, Guy, et al.. (1980). Estrogen-linked cytotoxic agents of potential value for the treatment of breast cancer.. PubMed. Suppl 1. 287–93. 3 indexed citations
18.
Paridaens, Robert, Richard Sylvester, Eros Ferrazzí, et al.. (1980). Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer. 46(S12). 2889–2895. 92 indexed citations
19.
20.
Heuson, Jean-Claude & Nicole Legros. (1970). Effect of insulin and of alloxan diabetes on growth of the rat mammary carcinoma in vivo. European Journal of Cancer (1965). 6(4). 349–351. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mels Sluyser Breakdown of academic impact, for papers by Eric C. Dietze Breakdown of academic impact, for papers by Rajeshwari R. Mehta Breakdown of academic impact, for papers by Hideya Endo Breakdown of academic impact, for papers by Peter Ove Breakdown of academic impact, for papers by Karen J. Auborn Breakdown of academic impact, for papers by Stephanie J. Webb Breakdown of academic impact, for papers by J.C. Faye Breakdown of academic impact, for papers by Joan Cao Breakdown of academic impact, for papers by Debajit K. Biswas
Rankless by CCL
2026